Extended Release Tablets
PROCESS VALIDATION OF METFORMIN HYDROCHLORIDE EXTENDED RELEASE TABLETS USP 500MG
... Process development is actual transfer of the manufacturing process from R & D to production along with necessary knowledge & skill to be able to make the product, is referred to as technology transfer. The ...
8
FORMULATION AND DEVELOPMENT OF TRAMODOL HYDROCHLORIDE EXTENDED RELEASE TABLETS
... Analgesics are drugs which provide symptomatic relief from painful conditions. These drugs are very often consumed by patients suffering from acute and chronic pains. However these drugs are not consumed by patients as ...
7
RP-HPLC Method Development and Validation for the Quantitative Estimation of Mirabegron in Extended-Release Tablets
... The aim of this study was to carry out development and validation of Mirabegron by RP-HPLC method in the Extended-Release tablets. The proposed HPLC method is rapid, sensitive, precise, simple and ...
5
FORMULATION DEVELOPMENT AND EVALUATION OF POTASSIUM CHLORIDE EXTENDED RELEASE TABLETS
... drug release, it causes local tissue irritation in the ...chloride extended release tablets, a few critical factors were identified such as low hardness, high friability, and rapid drug ...
13
FORMULATION AND EVALUATION OF EXTENDED RELEASE TABLETS OF METFORMIN HYDROCHLORIDE
... of extended release tablets of metformin HCl, which releases the drug in a extended manner over a period of 10 ...The tablets were prepared by wet granulation method and evaluated for ...
6
COMPARATIVE STUDY OF MARKETED METOPROLOL SUCCINATE EXTENDED RELEASE TABLETS
... of extended release tablets by pan coating ...of extended release polymers as ethyl cellulose 10 tab + HPMC (Hydroxy Propyl Methyl Cellulose), ethyl cellulose 10 tab + di ethyl ...
10
Pharmacokinetic and bioequivalence comparison between levetiracetam extended release tablets 750mg: An open label, balanced, randomizedsequence, single dose, two period crossover study in healthy male volunteers
... 750mg extended release tablets are bioequivalent to the reference formulation Keppra TM XR Levetiracetam 750mg Tablets in terms of extent and rate of absorption, under fed condition in healthy ...
7
Development and in vitro characterization of extended release tablets of levetiracetam
... In the present study, we attempted to formulate an extended release tablets of levetiracetam, a new generation antiepileptic drug used for the treatment of complex partial seizures. The goal of ...
5
DEVELOPMENT AND EVALUATION OF NANOSPONGES LOADED EXTENDED RELEASE TABLETS OF LANSOPRAZOLE
... loaded extended release tablets were prepared using HPMC K30 and chitosan and evaluated for flow properties and in-vitro drug release ...loaded extended release tablets ...
5
Formulation and Evaluation of Alfuzosin Hydrochloride Extended Release Tablets
... design extended release tablets which was capable of producing a 20 hrs extended release profile there by eliminating the use of immediate release tablets which require a ...
12
FORMULATION AND EVALUATION OF EXTENDED RELEASE TABLETS OF DARIFENACIN HYDROBROMIDE
... hydrobromide extended release tablets to extend the duration of action up to 24 hrs by controlling the dissolution rate using different viscosity grades of ...hydrobromide extended ...
5
Formulation and in-vitro evaluation of stavudine extended release tablets
... sustained release formulation of Stavudine is ...sustained release matrix tablets of Stavudine using putative hydrophilic matrix materials such as hydroxyl propyl methyl cellulose (HPMC) K15M, Sodium ...
11
FORMULATION AND EVALUATION OF EXTENDED RELEASE TABLETS OF METFORMIN HYDROCHLORIDE
... required moisture content is obtained. (NMT 1- 2%). Then the granules are size reduced, using sieve#20.The granules were finally lubricated using magnesium stearate after sifting it through #60,for5minutes.The lubricated ...
7
FORMULATION AND CHARACTERIZATION OF GALANTAMINE HYDROBROMIDE EXTENDED RELEASE TABLETS
... oral extended release tablets of Galantamine Hydrobromide which can be used to moderate or delay the manifestation of Alzheimer’s disease symptoms, using HPC HXF as the retardant polymer and to study ...
7
FORMULATION AND EVALUATION OF EXTENDED RELEASE TABLETS OF TRAMADOL HYDROCHLORIDE
... prepared extended release tablets were evaluated for hardness, thickness, friability, weight variation test and drug ...of tablets was tested using Monsanto hardness tester (Serve well, ...
5
FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE TABLETS OF TAPENTADOL HCl
... It is imperative to summarize the findings of the dissertation entitled “Formulation Development and Evaluation of Extended Release Tablets of Tapentadol HCl”. Prior to the development of dosage ...
11
GEOMATRIX TECHNOLOGY: FORMULATION AND EVALUATION OF STAVUDINE EXTENDED RELEASE TABLETS
... Hydrophilic polymers have been given considerable attention in the formulation of extended release drug delivery systems for various drugs. HPMC and ethyl cellulose are few representative examples of the ...
12
EFFECT OF PROCESSING AND POLYMER VARIABLES ON INVITRO RELEASE OF METOPROLOL SUCCINATE EXTENDED RELEASE TABLETS
... Hydrophilic polymer matrix systems are widely used in oral controlled drug delivery because they make it easier to achieve a desirable drug-release profile, they are cost-effective, and they have broad US Food and ...
7
Formulation and evaluation of bisoprolol fumarate extended release tablets
... commonly release the drug either in the zero order or in the first order ...pattern. Extended release dosage forms of Bisoprolol fumarate were prepared and studied for their dissolution ...The ...
22
Design development and evaluation of extended release tablets of Alfuzosin hydrochloride
... the tablets (n=3) was determined using monsanto hardness ...the tablets were checked using Roche ...of tablets (n=10) was placed in the friabilator, it was operated for 100 ...revolutions. ...
7